We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

354 hedge funds and large institutions have $6.43B invested in Bio-Rad Laboratories Class A in 2019 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 148 increasing their positions, 97 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 29

53% more repeat investments, than reductions

Existing positions increased: 148 | Existing positions reduced: 97

10% more capital invested

Capital invested by funds: $5.87B → $6.43B (+$562M)

7% more funds holding

Funds holding: 330 → 354 (+24)

2.26% more ownership

Funds ownership: 75.91% → 78.17% (+2.3%)

36% less funds holding in top 10

Funds holding in top 10: 11 → 7 (-4)

69% less call options, than puts

Call options by funds: $9.75M | Put options by funds: $31.4M

Holders
354
Holders Change
+24
Holders Change %
+7.27%
% of All Funds
7.76%
Holding in Top 10
7
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-36.36%
% of All Funds
0.15%
New
54
Increased
148
Reduced
97
Closed
29
Calls
$9.75M
Puts
$31.4M
Net Calls
-$21.7M
Net Calls Change
-$37.2M

Top Buyers

1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$121M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$96.4M
3
BlackRock
BlackRock
New York
+$48.4M
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$37M
5
Citadel Advisors
Citadel Advisors
Florida
+$34.7M

Top Sellers

1
EIP
Easterly Investment Partners
Massachusetts
-$120M
2
Russell Investments Group
Russell Investments Group
United Kingdom
-$61.1M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$47.9M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$28.5M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$26.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Principal Financial Group
51
Principal Financial Group
Iowa
$31.2M +$1.79M +5,492 +6%
N
52
Nuveen
North Carolina
$30.7M +$3.29M +10,076 +12%
AIM
53
Artemis Investment Management
United Kingdom
$30M +$11.6M +35,638 +63%
PPA
54
Parametric Portfolio Associates
Washington
$28.7M +$1.18M +3,627 +4%
Artisan Partners
55
Artisan Partners
Wisconsin
$28.6M +$2.58M +7,902 +10%
Prudential Financial
56
Prudential Financial
New Jersey
$27.8M +$1.59M +4,868 +6%
Allianz Asset Management
57
Allianz Asset Management
Germany
$27.3M +$12.1M +37,096 +82%
SSA
58
Schonfeld Strategic Advisors
New York
$27.2M +$7.2M +22,072 +37%
PCM
59
Portolan Capital Management
Massachusetts
$26.6M -$1.65M -5,053 -6%
Marshall Wace
60
Marshall Wace
United Kingdom
$26.2M +$18.7M +57,281 +267%
MGM
61
Miura Global Management
New York
$25M +$24.5M +75,000 New
PAMU
62
Pictet Asset Management (UK)
United Kingdom
$24.8M – – –
First Trust Advisors
63
First Trust Advisors
Illinois
$24M -$9.19M -28,184 -28%
CS
64
Candriam SCA
Luxembourg
$22.8M +$7.72M +23,660 +53%
UBS Group
65
UBS Group
Switzerland
$22.7M -$5.94M -18,219 -21%
RA
66
Royce & Associates
New York
$22.3M -$1.29M -3,953 -6%
PA
67
Perceptive Advisors
New York
$21.6M +$21.2M +65,000 New
JP Morgan Chase
68
JP Morgan Chase
New York
$20.3M +$5.53M +16,960 +39%
Franklin Resources
69
Franklin Resources
California
$19.8M -$1.61M -4,933 -8%
Ameriprise
70
Ameriprise
Minnesota
$19.8M +$185K +567 +1%
Legal & General Group
71
Legal & General Group
United Kingdom
$19.3M +$3.31M +10,137 +21%
Squarepoint
72
Squarepoint
New York
$19.1M +$18.7M +57,286 New
RhumbLine Advisers
73
RhumbLine Advisers
Massachusetts
$17.8M +$625K +1,915 +4%
Renaissance Technologies
74
Renaissance Technologies
New York
$17.7M -$25.6M -78,600 -60%
AIG
75
American International Group
New York
$16.3M +$618K +1,895 +4%
1 2
3
4 5

BIO Hedge Fund Activity: Q3 2019 in Review

354 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q3 2019, worth a combined $6.43B — up 9.6% from $5.87B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new BIO positions and 29 closed out — a net gain of 25 holders — while 148 added to existing stakes and 97 trimmed.

The largest buyer was Acadian Asset Management, opening a new position worth an estimated $121M. The largest seller was Easterly Investment Partners, cutting an estimated $120M.

  • 354 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q3 2019, up from 330 in Q2 2019.
  • Funds reported $6.43B of Bio-Rad Laboratories Class A stock for Q3 2019, up 9.6% quarter-over-quarter.
  • 54 funds opened new Bio-Rad Laboratories Class A positions in Q3 2019 and 29 closed out, a net change of +25 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q3 2019 was Acadian Asset Management, an estimated $121M added.
  • The largest Bio-Rad Laboratories Class A seller in Q3 2019 was Easterly Investment Partners, an estimated $120M sold.

Based on aggregated 13F filings for Q3 2019.